Apathy in neuropsychiatric disease: Diagnosis, pathophysiology, and treatment

Neurotoxicity Research

Volumn 19, Issue 2, 2011, Pages 266-278

  Chase, Thomas N ^a  

^a NONE

Author keywords

Alzheimer's disease; Basal ganglia; Depression; Parkinson's disease; Prefrontal cortex; Schizophrenia; Therapeutics

Indexed keywords

AMANTADINE; AMFEBUTAMONE; AMPHETAMINE; ATYPICAL ANTIPSYCHOTIC AGENT; CHOLINESTERASE INHIBITOR; CLOZAPINE; DONEPEZIL; DOPAMINE RECEPTOR STIMULATING AGENT; GALANTAMINE; MEMANTINE; METHYLPHENIDATE; MIRTAZAPINE; MODAFINIL; NEFIRACETAM; OLANZAPINE; PSYCHOSTIMULANT AGENT; RISPERIDONE; RIVASTIGMINE;

ALZHEIMER DISEASE; APATHY; APATHY EVALUATION SCALE; APATHY INVENTORY; APATHY SCALE; ARTICLE; BEHAVIOR DISORDER; BRAIN INFARCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DRUG MECHANISM; DRUG RESPONSE; FRONTAL SYSTEMS BEHAVIOR SCALE; FRONTOTEMPORAL DEMENTIA; HUMAN; LILLE APATHY RATING SCALE; MAJOR DEPRESSION; NEUROPSYCHIATRIC INVENTORY; NONHUMAN; OFF LABEL DRUG USE; PARKINSON DISEASE; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA; UNIFIED PARKINSON DISEASE RATING SCALE; UNSPECIFIED SIDE EFFECT;

ALZHEIMER DISEASE; ANIMALS; APATHY; HUMANS; MOTIVATION; PARKINSON DISEASE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 79751533753     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12640-010-9196-9     Document Type: Article

References (153)

1. P Aalten ME de Vugt N Jaspers J Jolles FR Verhey 2005 The course of neuropsychiatric symptoms in dementia. Part I: findings from the two-year longitudinal Maasbed study Int J Geriatr Psychiatry 20 6 523 530 15920712 10.1002/gps.1316 (Pubitemid 40873344)
2. P Aalten E van Valen ME de Vugt R Lousberg J Jolles FR Verhey 2006 Awareness and behavioral problems in dementia patients: a prospective study Int Psychogeriatr 18 1 3 17 16388704 10.1017/S1041610205002772
3. D Aarsland K Bronnick U Ehrt PP De Deyn S Tekin M Emre JL Cummings 2007 Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress J Neurol Neurosurg Psychiatry 78 36 42 1:STN:280:DC%2BD28jjs1Sntw%3D%3D 16820421 10.1136/jnnp.2005.083113 (Pubitemid 46048261)
4. E Acquas E Carboni P Leone G Di Chiara 1989 SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade? Psychopharmacology (Berl) 99 2 151 155 1:CAS:528:DyaL1MXlvVOgtbY%3D 10.1007/BF00442800 (Pubitemid 19215210)
5. GE Alexander MR DeLong PL Strick 1986 Parallel organization of functionally segregated circuits linking basal ganglia and cortex Annu Rev Neurosci 9 357 381 1:STN:280:DyaL283htlKksw%3D%3D 3085570 10.1146/annurev.ne.09. 030186.002041 (Pubitemid 16055790)
6. GS Alves CE Alves ME Lanna L Ericeira-Valente FK Sudo D Moreira E Engelhardt J Laks 2009 Clinical characteristics in subcortical ischemic white matter disease Arq Neuropsiquiatr 67 2A 173 178 19547804
7. S Andersson AM Bergedalen 2002 Cognitive correlates of apathy in traumatic brain injury Neuropsychiatry Neuropsychol Behav Neurol 15 3 184 191 12218711 (Pubitemid 35006773)
8. S Andersson JM Krogstad A Finset 1999 Apathy and depressed mood in acquired brain damage: relationship to lesion localization and psychophysiological reactivity Psychol Med 29 2 447 456 1:STN:280: DyaK1M3jtlehsg%3D%3D 10218936 10.1017/S0033291798008046 (Pubitemid 29129329)
9. P Angelelli S Paolucci U Bivona L Piccardi P Ciurli A Cantagallo G Antonucci L Fasotti A Di Santantonio MG Grasso L Pizzamiglio 2004 Development of neuropsychiatric symptoms in poststroke patients: a cross-sectional study Acta Psychiatr Scand 110 55 63 1:STN:280:DC%2BD2c3otVKgtw%3D%3D 15180780 10.1111/j.1600-0447.2004.00297.x (Pubitemid 38822648)
10. LG Apostolova GG Akopyan N Partiali CA Steiner RA Dutton KM Hayashi ID Dinov AW Toga JL Cummings PM Thompson 2007 Structural correlates of apathy in Alzheimer's disease Dement Geriatr Cogn Disord 24 2 91 97 17570907 10.1159/000103914 (Pubitemid 47094067)
11. NR Barbas 2006 Cognitive, affective, and psychiatric features of Parkinson's disease Clin Geriatr Med 22 4 773 796 17000335 10.1016/j.cger.2006. 06.004 (Pubitemid 44416144)
12. M Benoit S Clairet PM Koulibaly, et al. 2004 Brain perfusion correlates of the apathy inventory dimensions of Alzheimer's disease Int J Geriatr Psychiatry 19 864 869 1:STN:280:DC%2BD2cvktlGmtw%3D%3D 15352144 10.1002/gps.1163 (Pubitemid 39242892)
13. RM Bonelli JL Cummings 2007 Frontal-subcortical circuitry and behavior Dialogues Clin Neurosci 9 2 141 151 17726913 (Pubitemid 47075462)
14. LL Borek KL Chou JH Friedman 2007 Management of the behavioral aspects of Parkinson's disease Expert Rev Neurother 7 6 711 725 17563253 10.1586/14737175.7.6.711 (Pubitemid 46911618)
15. B Borroni C Agosti A Padovani 2008 Behavioral and psychological symptoms in dementia with Lewy-bodies (DLB): frequency and relationship with disease severity and motor impairment Arch Gerontol Geriatr 46 1 101 106 1:STN:280:DC%2BD2sjhsVKmtA%3D%3D 17467082 10.1016/j.archger.2007.03.003 (Pubitemid 350166585)
16. B Borroni A Alberici C Agosti M Cosseddu A Padovani 2009 Pattern of behavioral disturbances in corticobasal degeneration syndrome and progressive supranuclear palsy Int Psychogeriatr 21 3 463 468 19323870 10.1017/ S1041610209008862
17. RA Bressan JA Crippa 2005 The role of dopamine in reward and pleasure behaviour-review of data from preclinical research Acta Psychiatr Scand 111 427 Suppl 14 21 10.1111/j.1600-0447.2005.00540.x (Pubitemid 40780195)
18. H Brodaty PS Sachdev A Withall A Altendorf MJ Valenzuela L Lorentz 2005 Frequency and clinical, neuropsychological and neuroimaging correlates of apathy following stroke-the Sydney Stroke Study Psychol Med 35 1707 1716 16202190 10.1017/S0033291705006173 (Pubitemid 41672349)
19. PD Bruen WJ McGeown MF Shanks A Venneri 2008 Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer's disease Brain 131 Pt 9 2455 2463 18669506 10.1093/brain/awn151
20. R Cattelani R Roberti F Lombardi 2008 Adverse effects of apathy and neurobehavioral deficits on the community integration of traumatic brain injury subjects Eur J Phys Rehabil Med 44 3 245 251 1:STN:280:DC%2BD1crntlOmuw%3D%3D 18762734
21. DE Clarke R Reekum M Simard DL Streiner M Freedman D Conn 2007 Apathy in dementia: an examination of the psychometric properties of the apathy evaluation scale J Neuropsychiatry Clin Neurosci 19 1 57 64 17308228 (Pubitemid 46294446)
22. C Corcoran ML Wong V O'Keane 2004 Bupropion in the management of apathy J Psychopharmacol 18 1 133 135 1:STN:280:DC%2BD2c3htVSqtw%3D%3D 15107198 10.1177/0269881104043284 (Pubitemid 38623107)
23. D Craig A Mirakhur DJ Hart SP McIlroy AP Passmore 2005 A cross-sectional study of neuropsychiatric symptoms in 435 patients with Alzheimer's disease Am J Geriatr Psychiatry 13 460 468 15956265
24. FN Crespi 2002 Daiichi seiyaku Curr Opin Investig Drugs 3 5 788 793 1:CAS:528:DC%2BD38XlvVSgsr0%3D 12090554
25. JL Cummings M Mega K Gray S Rosenberg-Thompson DA Carusi J Gornbein 1994 The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia Neurology 44 12 2308 2314 1:STN:280:DyaK2M%2FotlWisw%3D%3D 7991117 (Pubitemid 24382728)
26. JL Cummings J Mackell D Kaufer 2008 Behavioral effects of current Alzheimer's disease treatments: a descriptive review Alzheimers Dement 4 1 49 60 1:CAS:528:DC%2BD1cXitlKhtrY%3D 18631950 10.1016/j.jalz.2007.10.011
27. V Czernecki M Schipbach S Yaici R Levy E Bardinet J Yelnik B Dubois Y Agid 2008 Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom Mov Disord 23 7 964 969 18398913 10.1002/mds.21949
28. LA Daiello 2007 Atypical antipsychotics for the treatment of dementia-related behaviors: an update Med Health R I 90 6 191 194 17633594
29. R David M Koulibaly M Benoit R Garcia H Caci J Darcourt P Robert 2008 Striatal dopamine transporter levels correlate with apathy in neurodegenerative diseases A SPECT study with partial volume effect correction Clin Neurol Neurosurg 110 1 19 24 17900799 10.1016/j.clineuro.2007.08.007 (Pubitemid 350266163)
30. SM DeFord MS Wilson CJ Gibson A Baranova RJ Hamm 2001 Nefiracetam improves Morris water maze performance following traumatic brain injury in rats Pharmacol Biochem Behav 69 3-4 611 616 1:CAS:528:DC%2BD3MXlvFWrsLo%3D 11509223 10.1016/S0091-3057(01)00559-7 (Pubitemid 32758748)
31. F Dellu PV Piazza W Mayo M Le Moal H Simon 1996 Novelty-seeking in rats-biobehavioral characteristics and possible relationship with the sensation-seeking trait in man Neuropsychobiology 34 3 136 145 1:STN:280:DyaK2s%2FntlentQ%3D%3D 8916071 10.1159/000119305 (Pubitemid 26355758)
32. C Derouesne 2004 Apathy: a useful but limited concept Psychol Neuropsychiatr Vieil 2 1 19 28 15683965
33. EE DeVito CH Salmond BK Owler BJ Sahakian JD Pickard 2007 Caudate structural abnormalities in idiopathic normal pressure hydrocephalus Acta Neurol Scand 116 5 328 332 1:STN:280:DC%2BD2sngtVGlug%3D%3D 17922726 10.1111/j.1600-0404.2007.00906.x (Pubitemid 47537420)
34. D Drapier J Peron E Leray P Sauleau I Biseul S Drapier F Le Jeune D Travers A Bourguignon C Haegelen B Millet M Virin 2008 Emotion recognition impairment and apathy after subthalamic nucleus stimulation in Parkinson's disease have separate neural substrates Neuropsychologia 46 11 2796 2801 1:STN:280:DC%2BD1cvntlGltg%3D%3D 18579165 10.1016/j.neuropsychologia.2008.05.006
35. RL Drijgers P Aalten A Winogrodzka FR Verhey AF Leentjens 2009 Pharmacological treatment of apathy in neurodegenerative diseases: a systematic review Dement Geriatr Cogn Disord 28 1 13 22 1:CAS:528:DC%2BD1MXhtVGgs7fE 19609082 10.1159/000228840
36. K Dujardin P Sockeel D Devos M Delliaux P Krystkowiak A Destee L Defebvre 2007 Characteristics of apathy in Parkinson's disease Mov Disord 22 6 778 784 17290451 10.1002/mds.21316 (Pubitemid 46800097)
37. K Dujardin P Sockeel M Delliaux A DestÈe L Defebvre 2008 The Lille Apathy Rating Scale: validation of a caregiver-based version Mov Disord 23 6 845 849 18307266 10.1002/mds.21968
38. A Faerden R Nesvåg EA Barrett I Agartz A Finset S Friis JI Rossberg I Melle 2008 Assessing apathy: the use of the Apathy Evaluation Scale in first episode psychosis Eur Psychiatry 23 1 33 39 18029152 10.1016/j.eurpsy.2007.09. 002 (Pubitemid 351221253)
39. A Faerden A Vaskinn A Finset I Agartz E Ann Barrett S Friis C Simonsen OA Andreassen I Melle 2009 Apathy is associated with executive functioning in first episode psychosis BMC Psychiatry 9 1 19133132 10.1186/1471-244X-9-1
40. AM Farrar M Pereira F Velasco J Hockemeyer CE Muller JD Salamone 2007 Adenosine A(2A) receptor antagonism reverses the effects of dopamine receptor antagonism on instrumental output and effort-related choice in the rat: implications for studies of psychomotor slowing Psychopharmacology (Berl) 191 3 579 586 1:CAS:528:DC%2BD2sXitlCqtbY%3D 10.1007/s00213-006-0554-5 (Pubitemid 46355890)
41. AM Farrar L Font M Pereira S Mingote JG Bunce JJ Chrobak JD Salamone 2008 Forebrain circuitry involved in effort-related choice: injections of the GABAA agonist muscimol into ventral pallidum alter response allocation in food-seeking behavior Neuroscience 152 2 321 330 1:CAS:528:DC%2BD1cXjs1Kqtb4%3D 18272291 10.1016/j.neuroscience.2007.12.034
42. M Fava LM Graves F Benazzi MJ Scalia DV Iosifescu JE Alpert GI Papakostas 2006 A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment J Clin Psychiatry 67 1754 1759 17196056 10.4088/JCP.v67n1113 (Pubitemid 44955157)
43. D Feil J Razani K Boone I Lesser 2003 Apathy and cognitive performance in older adults with depression Int J Geriatr Psychiatry 18 479 485 12789667 10.1002/gps.869 (Pubitemid 36763649)
44. F Ferreri C Agbokou S Gauthier 2006 Recognition and management of neuropsychiatric complications in Parkinson's disease CMAJ 175 12 1545 1552 17146092 (Pubitemid 44955118)
45. N Figved G Klevan KM Myhr S Glad H Nyland JP Larsen E Harboe R Omdal D Aarsland 2005 Neuropsychiatric symptoms in patients with multiple sclerosis Acta Psychiatr Scand 112 6 463 468 1:STN:280:DC%2BD2MngtVKrtw%3D%3D 16279876 10.1111/j.1600-0447.2005.00624.x (Pubitemid 41676691)
46. M Filali R Lalonde S Rivest 2009 Cognitive and non-cognitive behaviors in an APPswe/PS1 bigenic model of Alzheimer's disease Genes Brain Behav 8 2 143 148 1:CAS:528:DC%2BD1MXktlKkurw%3D 19077180 10.1111/j.1601-183X.2008.00453.x
47. S Freels D Cohen C Eisdorfer G Paveza P Gorelick DJ Luchins R Hirschman JW Ashford P Levy T Semla, et al. 1992 Functional status and clinical findings in patients with Alzheimer's disease J Gerontol 47 6 M177 M182 1:STN:280:DyaK3s%2Fls1WrtA%3D%3D 1430852
48. A Funkiewiez C Ardouin E Caputo P Krack V Fraix H Klinger S Chabardes K Foote AL Benabid P Pollak 2004 Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease J Neurol Neurosurg Psychiatry 75 6 834 839 1:STN:280: DC%2BD2c3kslGmtg%3D%3D 15145995 10.1136/jnnp.2002.009803 (Pubitemid 38658504)
49. JE Galvin H Malcom D Johnson JC Morris 2007 Personality traits distinguishing dementia with Lewy bodies from Alzheimer disease Neurology. 68 1895 1901 17536045 10.1212/01.wnl.0000263131.80945.ad (Pubitemid 46848621)
50. S Gauthier A Juby B Rehel R Schecter 2007 EXACT: rivastigmine improves the high prevalence of attention deficits and mood and behaviour symptoms in Alzheimer's disease Int J Clin Pract 61 6 886 895 1:CAS:528:DC%2BD2sXnsFSktL0%3D 17504350 10.1111/j.1742-1241.2007.01387.x (Pubitemid 46744076)
51. MW Ghobrial EB Ruby 2002 Coma and thyroid storm in apathetic thyrotoxicosis South Med J 95 5 552 554 12005017 (Pubitemid 34492345)
52. CG Goetz BC Tilley SR Shaftman GT Stebbins S Fahn P Martinez-Martin W Poewe C Sampaio MB Stern R Dodel B Dubois R Holloway J Jankovic J Kulisevsky AE Lang A Lees S Leurgans PA LeWitt D Nyenhuis CW Olanow O Rascol A Schrag JA Teresi JJ van Hilten N LaPelle UPDRS Movement Disorder Society Revision Task Force 2008 Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results Mov Disord 23 15 2129 2170 19025984 10.1002/mds.22340
53. AH Gouliaev A Senning 1994 Piracetam and other structurally related nootropics Brain Res Brain Res Rev 19 2 180 222 1:CAS:528:DyaK2cXmsVClsrc%3D 8061686 10.1016/0165-0173(94)90011-6 (Pubitemid 24150318)
54. C Haegelen T Rouaud P Darnault X Morandi 2009 The subthalamic nucleus is a key-structure of limbic basal ganglia functions Med Hypotheses 72 4 421 426 19157719 10.1016/j.mehy.2008.07.065
55. JM Hamilton DP Salmon J Corey-Bloom A Gamst JS Paulsen S Jerkins MW Jacobson G Peavy 2003 Behavioural abnormalities contribute to functional decline in Huntington's disease J Neurol Neurosurg Psychiatry 74 120 122 1:STN:280:DC%2BD3s%2FhsVeltg%3D%3D 12486282 10.1136/jnnp.74.1.120 (Pubitemid 36069050)
56. M Hasegawa S Nakayama H Kinoshita M Amano K Yamada T Hasegawa T Nabeshima 1996 Effects of the subacute administration of nefiracetam on abnormal behavior in aged rats Behav Brain Res 78 2 93 100 1:CAS:528:DyaK28Xls1Cqs78%3D 8864041 10.1016/0166-4328(95)00235-9 (Pubitemid 26252878)
57. J Jin S Watabe T Yamamoto 2002 Nefiracetam improves the impairment of local cerebral blood flow and glucose utilization after chronic focal cerebral ischemia in rats Pharmacology 64 119 125 1:CAS:528:DC%2BD38XhtVCnsb0%3D 11834887 10.1159/000056160 (Pubitemid 34136852)
58. R Joseph 1999 Frontal lobe psychopathology: mania, depression, confabulation, catatonia, perseveration, obsessive compulsions, and schizophrenia Psychiatry 62 2 138 172 1:STN:280:DyaK1MzkvVyquw%3D%3D 10420428
59. TA Ketter RM Post WH Theodore 1999 Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders Neurology 53 5 Suppl 2 53 67
60. M Kiang BK Christensen G Remington S Kapur 2003 Apathy in schizophrenia: clinical correlates and association with functional outcome Schizophr Res 63 79 88 12892861 10.1016/S0920-9964(02)00433-4 (Pubitemid 36929849)
61. EM Kingma E van Duijn R Timman RC van der Mast RA Roos 2008 Behavioural problems in Huntington's disease using the Problem Behaviours Assessment Gen Hosp Psychiatry 30 2 155 161 18291297 10.1016/j.genhosppsych.2007.11.005 (Pubitemid 351255558)
62. L Kirsch-Darrow HH Fernandez M Marsiske MS Okun D Bowers 2006 Dissociating apathy and depression in Parkinson disease Neurology 67 33 38 1:STN:280:DC%2BD28vhtFektg%3D%3D 16832074 10.1212/01.wnl.0000230572.07791.22 (Pubitemid 44305458)
63. L Kirsch-Darrow LB Zahodne C Hass A Mikos MS Okun HH Fernandez D Bowers 2009 How cautious should we be when assessing apathy with the Unified Parkinson's Disease Rating Scale? Mov Disord 24 5 684 688 19185011 10.1002/mds.22437
64. J Kulisevsky J Pagonabarraga B Pascual-Sedano C GarcÌa-Sanchez A Gironell Trapecio Group Study 2008 Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia Mov Disord 23 13 1889 1896 18709682 10.1002/mds.22246
65. KL Lanctot S Moosa N Herrmann FS Leibovitch L Rothenburg A Cotter SE Black 2007 A SPECT Study of Apathy in Alzheimer's Disease Dement Geriatr Cogn Disord 24 1 65 72 17565215 10.1159/000103633 (Pubitemid 46985293)
66. AM Landes SD Sperry ME Strauss DS Geldmacher 2001 Apathy in Alzheimer's disease J Am Geriatr Soc 49 12 1700 1:STN:280:DC%2BD387htVGmsA%3D%3D 11844006 10.1046/j.1532-5415.2001.49282.x (Pubitemid 34007999)
67. AM Landes SD Sperry ME Strauss 2005 Prevalence of apathy, dysphoria, and depression in relation to dementia severity in Alzheimer's disease J Neuropsychiatry Clin Neurosci 17 342 349 16179656 (Pubitemid 46179297)
68. Lane-Brown A, Tate R (2009) Interventions for apathy after traumatic brain injury. Cochrane Database Syst Rev Apr 15(2):CD006341
69. EC Lauterbach 2004 The neuropsychiatry of Parkinson's disease and related disorders Psychiatr Clin North Am 27 801 825 15550293 10.1016/j.psc.2004.07.001 (Pubitemid 39535129)
70. H Lavretsky M Ballmaier D Pham A Toga A Kumar 2007 Neuroanatomical characteristics of geriatric apathy and depression: a magnetic resonance imaging study Am J Geriatr Psychiatry 15 5 386 394 17463189 10.1097/JGP. 0b013e3180325a16
71. L Lechowski M Benoit P Chassagne I Vedel D Tortrat L Teillet B Vellas 2009 Persistent apathy in Alzheimer's disease as an independent factor of rapid functional decline: the REAL longitudinal cohort study Int J Geriatr Psychiatry 24 4 341 346 1:STN:280:DC%2BD1M3ivFeqsQ%3D%3D 18814198 10.1002/gps.2125
72. AF Leentjens K Dujardin L Marsh P Martinez-Martin IH Richard SE Starkstein D Weintraub C Sampaio W Poewe O Rascol GT Stebbins CG Goetz 2008 Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations Mov Disord 23 14 2004 2014 18709683 10.1002/mds.22229
73. AF Leentjens J Koester B Fruh DT Shephard P Barone JJ Houben 2009 The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies Clin Ther 31 1 89 98 1:CAS:528:DC%2BD1MXksl2rsb0%3D 19243709 10.1016/j.clinthera.2009.01.012
74. R Levy V Czernecki 2006 Apathy and the basal ganglia J Neurol 253 Suppl 7 54 61
75. R Levy B Dubois 2006 Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits Cereb Cortex 16 916 928 16207933 10.1093/cercor/bhj043 (Pubitemid 43992442)
76. ML Levy JL Cummings LA Fairbanks D Masterman BL Miller AH Craig JS Paulsen I Litvan 1998 Apathy is not depression J Neuropsychiatry Clin Neurosci 10 3 314 319 1:STN:280:DyaK1czntFyhug%3D%3D 9706539 (Pubitemid 28369627)
77. U Lueken U Seidl L Völker E Schweiger A Kruse J Schröder 2007 Development of a short version of the Apathy Evaluation Scale specifically adapted for demented nursing home residents Am J Geriatr Psychiatry 15 5 376 378 17463188 10.1097/JGP.0b013e3180437db3
78. J Luthman E Lindqvist H Kojima T Shiotani M Tanaka H Tachizawa L Olson 1994 Effects of nefiracetam (DM-9384), a pyrrolidone derivative, on brain monoamine systems Arch Int Pharmacodyn Ther 328 2 125 144 1:CAS:528: DyaK2MXjt1yjs7c%3D 7535993
79. AK Malla RM Norman P Williamson 1993 Stability of positive and negative symptoms in schizophrenia Can J Psychiatry 38 9 617 621 1:STN:280: DyaK2c7jvVyhtg%3D%3D 8306235 (Pubitemid 24028437)
80. P Malloy J Grace 2005 A review of rating scales for measuring behavior change due to frontal systems damage Cogn Behav Neurol 18 1 18 27 15761273 10.1097/01.wnn.0000152232.47901.88 (Pubitemid 40381366)
81. LB Marangell CR Johnson B Kertz HA Zboyan JM Martinez 2002 Olanzapine in the treatment of apathy in previously depressed participants maintained with selective serotonin reuptake inhibitors: an open-label, flexible-dose study J Clin Psychiatry 63 5 391 395 1:CAS:528:DC%2BD38XksVCjt7g%3D 12019662 (Pubitemid 34507215)
82. RS Marin 1990 Differential diagnosis and classification of apathy Am J Psychiatry 147 1 22 30 1:STN:280:DyaK3c%2FoslWgsA%3D%3D 2403472 (Pubitemid 20025502)
83. RS Marin 1996 Apathy: concept, syndrome, neural mechanisms, and treatment Semin Clin Neuropsychiatry 1 304 314 10320433
84. RS Marin PA Wilkosz 2005 Disorders of diminished motivation J Head Trauma Rehabil 20 377 388 16030444 10.1097/00001199-200507000-00009 (Pubitemid 40923449)
85. RS Marin RC Biedrzycki S Firinciogullari 1991 Reliability and validity of the Apathy Evaluation Scale Psychiatry Res 38 2 143 162 1:STN:280: DyaK38%2FpsVSnug%3D%3D 1754629 10.1016/0165-1781(91)90040-V
86. RS Marin MA Butters BH Mulsant BG Pollock CF Reynolds 2003 Apathy and executive function in depressed elderly J Geriatr Psychiatry Neurol 16 112 116 12801162 10.1177/0891988703016002009 (Pubitemid 37409040)
87. GA Marshall LA Fairbanks S Tekin HV Vinters JL Cummings 2006 Neuropathologic correlates of apathy in Alzheimer's disease Dement Geriatr Cogn Disord 21 3 144 147 16391476 10.1159/000090674 (Pubitemid 43201323)
88. GA Marshall L Monserratt D Harwood M Mandelkern JL Cummings DL Sultzer 2007 Positron emission tomography metabolic correlates of apathy in Alzheimer disease Arch Neurol 64 7 1015 1020 17620493 10.1001/archneur.64.7.1015 (Pubitemid 47048003)
89. L Massimo C Powers P Moore L Vesely B Avants J Gee DJ Libon M Grossman 2009 Neuroanatomy of apathy and disinhibition in frontotemporal lobar degeneration Dement Geriatr Cogn Disord 27 1 96 104 19158440 10.1159/000194658
90. NE Mayo LK Fellows SC Scott J Cameron S Wood-Dauphinee 2009 A longitudinal view of apathy and its Impact after stroke Stroke 40 10 3299 3307 19713543 10.1161/STROKEAHA.109.554410
91. TW McAllister 2000 Apathy Semin Clin Neuropsychiatry 5 275 282 1:STN:280:DC%2BD3MzgslWitw%3D%3D 11291024 10.1053/scnp.2000.9557
92. MF Mendez EC Lauterbach SM Sampson 2008 ANPA Committee on Research. An evidence-based review of the psychopathology of frontotemporal dementia: a report of the ANPA Committee on Research J Neuropsychiatry Clin Neurosci 20 2 130 149 18451185
93. O Migneco M Benoit PM Koulibaly I Dygai C Bertogliati P Desvignes PH Robert G Malandain F Bussiere J Darcourt 2001 Perfusion brain SPECT and statistical parametric mapping analysis indicate that apathy is a cingulate syndrome: a study in Alzheimer's disease and non-demented patients Neuroimage 13 896 902 1:STN:280:DC%2BD3MzpsFejtg%3D%3D 11304085 10.1006/nimg.2000.0741 (Pubitemid 32848334)
94. R Mizrahi SE Starkstein 2007 Epidemiology and management of apathy in patients with Alzheimer's disease Drugs Aging 24 7 547 554 1:CAS:528: DC%2BD2sXhtVeqtLnN 17658906 10.2165/00002512-200724070-00003 (Pubitemid 47195674)
95. S Moriguchi N Shioda H Maejima X Zhao W Marszalec JZ Yeh K Fukunaga T Narahashi 2007 Nefiracetam potentiates N-methyl-D-aspartate (NMDA) receptor function via protein kinase C activation and reduces magnesium block of NMDA receptor Mol Pharmacol 71 2 580 587 1:CAS:528:DC%2BD2sXhsVWrsLs%3D 17095583 10.1124/mol.106.027607 (Pubitemid 46147922)
96. E Ohtomo 1994 Post stroke behavioral abnormalities treated with nefiracetam (DM9384) Igaku No Ayumi [J Clin Exp Med] 170 9 777 816 Japanese
97. K Okada S Kobayashi S Yamagata K Takahashi S Yamaguchi 1997 Poststroke apathy and regional cerebral blood flow Stroke 28 12 2437 2441 1:STN:280:DyaK1c%2FnsVWjtg%3D%3D 9412628 (Pubitemid 28007646)
98. PR Padala WJ Burke SC Bhatia 2007 Modafinil therapy for apathy in an elderly patient Ann Pharmacother 41 2 346 349 1:CAS:528:DC%2BD2sXjsF2ktbY%3D 17264158 10.1345/aph.1H302 (Pubitemid 46340067)
99. PR Padala WJ Burke VK Shostrom SC Bhatia SP Wengel JF Potter F Petty 2010 Methylphenidate for apathy and functional status in dementia of the Alzheimer type Am J Geriatr Psychiatry 18 4 371 374 20220576 10.1097/JGP.0b013e3181cabcf6
100. KF Pedersen JP Larsen D Aarsland 2008 Validation of the Unified Parkinson's Disease Rating Scale (UPDRS) section I as a screening and diagnostic instrument for apathy in patients with Parkinson's disease Parkinsonism Relat Disord 14 3 183 186 17889589 10.1016/j.parkreldis.2007.07.015 (Pubitemid 351458418)
101. KF Pedersen JP Larsen G Alves D Aarsland 2009 Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study Parkinsonism Relat Disord 15 4 295 299 18801696 10.1016/j.parkreldis.2008.07.006
102. F Peters D Perani K Herholz V Holthoff B Beuthien-Baumann S Sorbi A Pupi C Degueldre C Lemaire F Collette E Salmon 2006 Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia Dement Geriatr Cogn Disord 21 5-6 373 379 16534207 10.1159/000091898 (Pubitemid 43735682)
103. GC Pluck RG Brown 2002 Apathy in Parkinson's disease J Neurol Neurosurg Psychiatry 73 6 636 642 1:STN:280:DC%2BD38nnvVGksA%3D%3D 12438462 10.1136/jnnp.73.6.636 (Pubitemid 35448846)
104. SM Ramirez H Glover C Ohlde R Mercer P Goodnick C Hamlin MI Perez-Rivera 2001 Relationship of numbing to alexithymia, apathy, and depression Psychol Rep 88 1 189 200 1:STN:280:DC%2BD3MzpsVGmtQ%3D%3D 11293028 10.2466/PR0.88.1.189-200 (Pubitemid 33600409)
105. JS Reijnders U Ehrt R Lousberg D Aarsland AF Leentjens 2009 The association between motor subtypes and psychopathology in Parkinson's disease Parkinsonism Relat Disord 15 5 379 382 1:STN:280:DC%2BD1MzkslKjsw%3D%3D 18977165 10.1016/j.parkreldis.2008.09.003
106. P Remy M Doder A Lees N Turjanski D Brooks 2005 Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system Brain 128 Pt 6 1314 1322 15716302 10.1093/brain/awh445 (Pubitemid 40826185)
107. S Reyes A Viswanathan O Godin C Dufouil S Benisty K Hernandez A Kurtz E Jouvent M O'Sullivan V Czernecki MG Bousser M Dichgans H Chabriat 2009 Apathy: a major symptom in CADASIL Neurology 72 10 905 910 1:STN:280: DC%2BD1M7psleqtQ%3D%3D 19273824 10.1212/01.wnl.0000344166.03470.f8
108. PH Robert S Clairet M Benoit J Koutaich C Bertogliati O Tible H Caci M Borg P Brocker P Bedoucha 2002 The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment Int J Geriatr Psychiatry 17 12 1099 1105 1:STN:280: DC%2BD38npvFequw%3D%3D 12461757 10.1002/gps.755 (Pubitemid 35469216)
109. PH Robert C Berr M Volteau C Bertogliati M Benoit M Sarazin S Legrain B Dubois the PréAL study 2006 Apathy in patients with mild cognitive impairment and the risk of developing dementia of Alzheimer's disease: a one-year follow-up study Clin Neurol Neurosurg 108 733 736 16567037 10.1016/j.clineuro.2006.02.003 (Pubitemid 44709787)
110. P Robert CU Onyike AF Leentjens K Dujardin P Aalten S Starkstein FR Verhey J Yessavage JP Clement D Drapier F Bayle M Benoit P Boyer PM Lorca F Thibaut S Gauthier G Grossberg B Vellas J Byrne 2009 Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders Eur Psychiatry 24 2 98 104 1:STN:280:DC%2BD1M7nsVersA%3D%3D 19201579 10.1016/j.eurpsy.2008.09.001
111. RG Robinson FE Bloom 1977 Pharmacological treatment following experimental cerebral infarction: implications for understanding psychological symptoms of human stroke Biol Psychiatry 12 5 669 680 1:CAS:528: DyaE1cXitVWkug%3D%3D 588647 (Pubitemid 8225387)
112. RG Robinson RE Jorge K Clarence-Smith S Starkstein 2009 Double-blind treatment of apathy in patients with poststroke depression using nefiracetam J Neuropsychiatry Clin Neurosci 21 144 151 1:CAS:528:DC%2BD1MXht1yntrjL 19622685
113. J Rodda S Morgan Z Walker 2009 Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine Int Psychogeriatr 21 5 813 824 19538824 10.1017/S1041610209990354
114. F Roselli NM Pisciotta R Perneczky M Pennelli MS Aniello MF De Caro E Ferrannini B Tartaglione G Defazio G Rubini P Livrea 2009 Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: a 123I-FP-CIT SPECT study Mov Disord 24 14 2097 2103 19705471 10.1002/mds.22702
115. HJ Rosen SC Allison GF Schauer ML Gorno-Tempini MW Weiner BL Miller 2005 Neuroanatomical correlates of behavioural disorders in dementia Brain 128 11 2612 2625 16195246 10.1093/brain/awh628 (Pubitemid 41552946)
116. RM Roth LA Flashman AJ Saykin TW McAllister R Vidaver 2004 Apathy in schizophrenia: reduced frontal lobe volume and neuropsychological deficits Am J Psychiatry 161 157 159 14702265 10.1176/appi.ajp.161.1.157 (Pubitemid 38419322)
117. RM Roth LA Flashman TW McAllister 2007 Apathy and its treatment Curr Treat Options Neurol 9 5 363 370 17716600 (Pubitemid 47377238)
118. MF Rushworth TE Behrens PH Rudebeck ME Walton 2007 Contrasting roles for cingulate and orbitofrontal cortex in decisions and social behaviour Trends Cogn Sci 11 4 168 176 1:STN:280:DC%2BD2s7pt1ahtA%3D%3D 17337237 10.1016/j.tics.2007. 01.004 (Pubitemid 46467492)
119. T Sakurai T Kato K Mori E Takano S Watabe T Nabeshima 1998 Nefiracetam elevates extracellular acetylcholine level in the frontal cortex of rats with cerebral cholinergic dysfunctions: an in vivo microdialysis study Neurosci Lett 246 2 69 72 1:CAS:528:DyaK1cXitlSqt7c%3D 9627182 10.1016/S0304-3940(98)00244-4 (Pubitemid 28207078)
120. Samus QM, Rosenblatt A, Steele C, Baker A, Harper M, Brandt J, Mayer L, Rabins PV, Lyketsos CG (2005) The association of neuropsychiatric symptoms and environment with quality of life in assisted living residents with dementia. Gerontologist 45 Spec No 1(1):19-26 (Pubitemid 41606919)
121. N Santa H Sugimori K Kusuda Y Yamashita S Ibayashi M Iida 2008 Apathy and functional recovery following first-ever stroke Int J Rehabil Res 31 4 321 326 19008681 10.1097/MRR.0b013e3282fc0f0e
122. H Siddique LS Hynan MF Weiner 2009 Effect of a serotonin reuptake inhibitor on irritability, apathy, and psychotic symptoms in patients with Alzheimer's disease J Clin Psychiatry 70 6 915 918 1:CAS:528:DC%2BD1MXhsFentbbJ 19422762 10.4088/JCP.08m04828
123. P Sockeel K Dujardin D Devos C Deneve A Destee L Defebvre 2006 The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's disease J Neurol Neurosurg Psychiatry 77 5 579 584 1:STN:280:DC%2BD283ltFKmtQ%3D%3D 16614016 10.1136/jnnp.2005.075929 (Pubitemid 43844578)
124. DR Spiegel J Kim K Greene C Conner D Zamfir 2009 Apathy due to cerebrovascular accidents successfully treated with methylphenidate: a case series J Neuropsychiatry Clin Neurosci 21 2 216 219 1:CAS:528:DC%2BD1MXht1yntrjE 19622693
125. SE Starkstein AF Leentjens 2008 The nosological position of apathy in clinical practice J Neurol Neurosurg Psychiatry 79 10 1088 1092 1:STN:280:DC%2BD1cngs1yksw%3D%3D 18187477 10.1136/jnnp.2007.136895
126. SE Starkstein M Merello 2007 The Unified Parkinson's Disease Rating Scale: validation study of the mentation, behavior, and mood section Mov Disord 22 15 2156 2161 17721877 10.1002/mds.21521
127. SE Starkstein HS Mayberg TJ Preziosi P Andrezejewski R Leiguarda RG Robinson 1992 Reliability, validity, and clinical correlates of apathy in Parkinson's disease J Neuropsychiatry Clin Neurosci 4 2 134 139 1:STN:280:DyaK38zjtVCqsQ%3D%3D 1627973
128. SE Starkstein JP Fedoroff TR Price R Leiguarda RG Robinson 1993 Apathy following cerebrovascular lesions Stroke 24 11 1625 1630 1:STN:280: DyaK2c%2FlsVGhtw%3D%3D 8236333 (Pubitemid 23315865)
129. SE Starkstein G Petracca E Chemerinski J Kremer 2001 Syndromic validity of apathy in Alzheimer's disease Am J Psychiatry 158 6 872 877 1:STN:280:DC%2BD3MzhtFCgtw%3D%3D 11384893 10.1176/appi.ajp.158.6.872 (Pubitemid 32547615)
130. SE Starkstein R Jorge R Mizrahi RG Robinson 2006 A prospective longitudinal study of apathy in Alzheimer's disease J Neurol Neurosurg Psychiatry 77 1 8 11 1:STN:280:DC%2BD2MnntlOktA%3D%3D 16361584 10.1136/jnnp.2005.069575 (Pubitemid 43022682)
131. SE Starkstein M Merello R Jorge S Brockman D Bruce B Power 2009 The syndromal validity and nosological position of apathy in Parkinson's disease Mov Disord 24 8 1211 1216 19412942 10.1002/mds.22577
132. JC Stout RE Ready J Grace PF Malloy JS Paulsen 2003 Factor analysis of the frontal systems behavior scale (FrSBe) Assessment 10 1 79 85 12675387 10.1177/1073191102250339 (Pubitemid 44534450)
133. M Svetel A Potrebić T Pekmezović A Tomić N Kresojević R Jesić N Dragasević VS Kostić 2009 Neuropsychiatric aspects of treated Wilson's disease Parkinsonism Relat Disord 15 10 772 775 19559640 10.1016/j.parkreldis.2009.01.010
134. MM Swanberg 2007 Memantine for behavioral disturbances in frontotemporal
135. P Tagariello P Girardi M Amore 2009 Depression and apathy in dementia: same syndrome or different constructs? A critical review Arch Gerontol Geriatr 49 2 246 249 1:STN:280:DC%2BD1MvnvV2ntQ%3D%3D 19022508 10.1016/j.archger.2008. 09.002
136. S Takeo T Fukatsu K Miyake-Takagi N Takagi M Niimura A Nagakura T Ando K Tanonaka 2003 Persistent effects of delayed treatment with nefiracetam on the water maze task in rats with sustained cerebral ischemia J Pharmacol Exp Ther 304 2 513 523 1:CAS:528:DC%2BD3sXpvVChug%3D%3D 12538802 10.1124/jpet.102.043653 (Pubitemid 36152325)
137. S Takeo M Niimura K Miyake-Takagi A Nagakura T Fukatsu T Ando N Takagi K Tanonaka J Hara 2003 A possible mechanism for improvement by a cognition-enhancer nefiracetam of spatial memory function and cAMP-mediated signal transduction system in sustained cerebral ischaemia in rats Br J Pharmacol 138 4 642 654 1:CAS:528:DC%2BD3sXitlCktr8%3D 12598418 10.1038/sj.bjp.0705096 (Pubitemid 36315312)
138. S Tekin JL Cummings 2002 Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update J Psychosom Res 53 2 647 654 12169339 10.1016/S0022-3999(02)00428-2 (Pubitemid 36292444)
139. JC Thompson JS Snowden D Craufurd D Neary 2002 Behavior in Huntington's disease: dissociating cognition-based and mood-based changes J Neuropsychiatry Clin Neurosci 14 1 37 43 11884653 (Pubitemid 34117021)
140. O Turro-Garriga S Lopez-Pousa J Vilalta-Franch A Turon-Estrada I Pericot-Nierga M Lozano-Gallego M Hernandez-Ferrandiz O Soler-Cors X Planas-Pujol S Monserrat-Vila J Garre-Olmo 2009 A longitudinal study of apathy in patients with Alzheimer's disease Rev Neurol 48 1 7 13 1:STN:280: DC%2BD1M%2Fnt1Ohuw%3D%3D 19145559
141. E van Duijn EM Kingma RC van der Mast 2007 Psychopathology in verified Huntington's disease gene carriers J Neuropsychiatry Clin Neurosci 19 4 441 448 18070848 (Pubitemid 350156103)
142. R van Reekum DT Stuss L Ostrander 2005 Apathy: why care? J Neuropsychiatry Clin Neurosci 17 7 19 15746478 (Pubitemid 40283765)
143. DI Velligan JL Ritch D Sui M DiCocco CD Huntzinger 2002 Frontal Systems Behavior Scale in schizophrenia: relationships with psychiatric symptomatology, cognition and adaptive function Psychiatry Res 113 3 227 236 12559479 10.1016/S0165-1781(02)00264-0 (Pubitemid 36136045)
144. B Vicini Chilovi M Conti M Zanetti I Mazzu L Rozzini A Padovani 2009 Differential impact of apathy and depression in the development of dementia in mild cognitive impairment patients Dement Geriatr Cogn Disord 27 4 390 398 19339777 10.1159/000210045
145. DY von Cramon G Matthes-von Cramon 1994 Recovery of higher-order cognitive deficits after brain hypoxia or frontomedial vascular lesions Appl Neuropsychol 1 1-2 2 7 10.1207/s15324826an0101&2-2
146. S Watabe K Taniguchi H Kojima 1994 Improvement of impaired brain monoamine metabolism by the cognition-enhancing agent nefiracetam after microsphere-induced cerebral embolism in rats Arzneimittelforschung 44 2 195 198 1:CAS:528:DyaK2cXlsVyqtbc%3D 7517140 (Pubitemid 24107056)
147. D Weintraub PJ Moberg JE Duda IR Katz MB Stern 2004 Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease J Am Geriatr Soc 52 5 784 788 15086662 10.1111/j.1532-5415.2004.52219.x (Pubitemid 38596500)
148. P Wicks S Abrahams B Papps A Al-Chalabi CE Shaw PN Leigh LH Goldstein 2009 SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis J Neurol 256 2 234 241 1:CAS:528:DC%2BD1MXjtF2mtrs%3D 19252762 10.1007/s00415-009-0078-0
149. N Wongpakaran R van Reekum T Wongpakaran D Clarke 2007 Selective serotonin reuptake inhibitor use associates with apathy among depressed elderly: a case-control study Ann Gen Psychiatry 6 7 17313684 10.1186/1744-859X-6-7 (Pubitemid 46404374)
150. CA Yeager L Hyer 2008 Apathy in dementia: relations with depression, functional competence, and quality of life Psychol Rep 102 3 718 722 18763441 10.2466/pr0.102.3.718-722
151. M Yoshii S Watabe YL Murashima T Nukada T Shiotani 2000 Cellular mechanism of action of cognitive enhancers: effects of nefiracetam on neuronal Ca2+ channels Alzheimer Dis Assoc Disord 14 Suppl 1 S95 S102 1:CAS:528:DC%2BD3cXktlWrtrc%3D 10850736
152. LB Zahodne S Young L Kirsch-Darrow A Nisenzon HH Fernandez MS Okun D Bowers 2009 Examination of the Lille Apathy Rating Scale in Parkinson disease Mov Disord 24 5 677 683 19133658 10.1002/mds.22441
153. G Zamboni ED Huey F Krueger PF Nichelli J Grafman 2008 Apathy and disinhibition in frontotemporal dementia: insights into their neural correlates Neurology 71 10 736 742 1:STN:280:DC%2BD1crnslCgsw%3D%3D 18765649 10.1212/01.wnl.0000324920.96835.95